Skip to search formSkip to main contentSkip to account menu

CS 7017

Known as: CS-7017, CS7017 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

Efatutazone Dihydrochloride
PPAR gamma agonist CS-7017

Broader (1)

efatutazone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Abstract 1278: Phase 1 study of CS-7017, an oral PPAR-γ agonist, in combination with paclitaxel in advanced anaplastic thyroid cancer
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Background: Stage IVC (metastatic) anaplastic thyroid… 
2011
2011
Abstract 1311: Disposition and biotransformation of [14C]-radiolabeled CS-7017 in healthy male subjects
Background: CS-7017 is a novel, oral, highly potent and selective peroxisome proliferator-activated receptor gamma agonist with… 
2011
2011
9059 POSTER Phase 1b Study of Oral PPAR-gamma Agonist Efatutazone (CS-7017) in Combination With Carboplatin and Paclitaxel in Chemotherapy-Naive Korean Patients With Metastatic or Unresectable…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)